跳至主要内容
临床试验/IRCT20140126016374N2
IRCT20140126016374N2已完成3 期

The study of of Escitalopram ?s effectiveness on treatment of mild to moderate depressive disorder and improvement of quality of life in patients who are undergone coronary artery bypass graft surgery (CABG) – A randomized double blind placebo controlled trial

niversity of social welfare and rehabilitation sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • coronary artery bypass graft surgery
  • Age >18 (18-75)
  • patient with beck depression inventory score 10-20

排除标准

  • Previous history of intolerance to serotonin reuptake inhibitor antidepressants
  • Psychosis or dementia or mental retardation disorder in the patient
  • Severe liver disease
  • High risk of postoperative cardiac complications such as bleeding
  • Patients participating in other trials
  • History of bipolar disorder
  • Patients who have been treated with escitalopram or an antidepressant during the previous month
  • Recent abuse of alcohol and substances
  • Pregnancy and lactation

研究者

发起方
niversity of social welfare and rehabilitation sciences

相似试验